Breaking News Instant updates and real-time market news.

C

Citi

$48.36

-0.34 (-0.70%)

, COST

Costco

$150.46

-0.55 (-0.36%)

14:53
10/13/16
10/13
14:53
10/13/16
14:53

On The Fly: What to watch in Citigroup earnings report

Citigroup (C) is scheduled to report results of its third fiscal quarter before the market open on October 14, with a conference call scheduled for 11:30 am EDT. What to watch for: 1. STREET LOWERING EXPECTATIONS: On Tuesday, Compass Point analyst Charles Peabody initiated Citi with a Sell, saying earnings continue to look weak combined with soft international and capital markets. On September 13, research firm Societe Generale also downgraded Citi to Sell, citing an increased negative stance on cards. A few days later, Goldman analyst Richard Ramsden downgraded the stock to Neutral, saying Citi's expected earnings inflection has failed to materialize and return on equities are at 7.7%, well below management's 10% target. Further, he believes growth in higher return businesses, such as credit cards and wealth management, and expense discipline will not be enough to increase return on equity all the way to its target. 2. OUTLOOK MET?: During the company's last earnings call on July 15, Citi said it sees net interest margin recovering to 290 bps for rest of the year and stable underlying credit quality in its consumer bank. Additionally, the bank expects international consumer revenues to grow sequentially and investment banking revenues to be "stable" in the third quarter. Further, it sees core expenses at Citi Corp being down in the third quarter, with Citi Holdings breaking-even for the quarter. 3. CO-BRANDED COSTCO CARD: On July 15, Citi said it is targeting a 225-235 basis points return on assets on branded cards, and 250 basis points return on assets on co-branded cards. The bank also noted that it has put resources toward Costco (COST), anticipating good volume growth, but not as much as from the start of the investment program. Commenting on Costco's new co-branded credit card, which is a partnership with Visa (V), Oppenheimer analyst Brian Nagel said that new and existing members seem to be embracing it. Although the analyst acknowledged that initial data is limited, he estimated that since the launch of the new Costco-branded credit card, sign-ups have tracked as much as 250,000-290,000 higher than prior run rates, when Costco was partnered with American Express (AXP). 4. CLEARXCHANGE: Late last month, The Wall Street Journal reported that Citi was set to join its rivals in building a peer-to-peer payments app in an attempt to fend off fintech upstarts like PayPal's (PYPL) Venmo. To accomplish this, Citi will become a member of clearXchange, a real-time money movement network that includes Wells Fargo (WFC), J.P. Morgan. (JPM), Bank of America (BAC), U.S. Bancorp (USB) and others, the report added.

C

Citi

$48.36

-0.34 (-0.70%)

COST

Costco

$150.46

-0.55 (-0.36%)

V

Visa

$81.90

-0.35 (-0.43%)

AXP

American Express

$60.35

-0.345 (-0.57%)

WFC

Wells Fargo

$44.56

-0.765 (-1.69%)

JPM

JPMorgan

$67.55

-0.58 (-0.85%)

BAC

Bank of America

$15.78

-0.25 (-1.56%)

USB

U.S. Bancorp

$42.76

-0.645 (-1.49%)

  • 14

    Oct

  • 14

    Oct

  • 14

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 21

    Oct

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 03

    Nov

  • 14

    Nov

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

C Citi
$48.36

-0.34 (-0.70%)

10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Oppenheimer technical analyst upgrades Financials, downgrades Consumer Staples
Oppenheimer technical analyst Ari Wald upgraded the Financials sector to Market Weight and downgraded Consumer Staples to Underweight in next step in the firm's "cyclical rotation road map." Wald identified Ameriprise (AMP), Bank of America (BAC), Citi (C), Goldman Sachs (GS), Lincoln National (LNC) and SunTrust (STI) as six stocks breaking higher that he sees as likely to benefit from internal market rotation.
10/11/16
COMP
10/11/16
INITIATION
Target $39
COMP
Sell
Citi initiated with a Sell at Compass Point
Compass Point analyst Charles Peabody initiated Citi with a Sell and a $39 price target saying earnings continue to look week combined with soft international and capital markets.
09/16/16
GSCO
09/16/16
DOWNGRADE
GSCO
Neutral
Citi downgraded to Neutral from Buy at Goldman
Goldman analyst Richard Ramsden downgraded Citi to Neutral and lowered his price target on the shares to $50 from $52. The analyst said Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. Ramsden's analysis suggests growth in higher return businesses, such as credit cards and wealth management, and expense discipline will not be enough to increase ROE all the way to its 10% target. Citi remains a capital returns story, constrained by the utilization of deferred tax assets, the analyst wrote in his report.
09/16/16
09/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 21st Century Fox (FOX, FOXA) downgraded to Market Perform from Outperform at Bernstein with analyst Jason Park citing a reduction in his estimates for the company's Star India business. 2. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities. 3. Citi (C) downgraded to Neutral from Buy at Goldman with analyst Richard Ramsden saying Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. 4. McCormick (MKC) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard citing valuation. 5. Novavax (NVAX) downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Overweight at JPMorgan, to Neutral from Buy at Ladenburg, to Neutral from Outperform at Wedbush, and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COST Costco
$150.46

-0.55 (-0.36%)

09/23/16
BARD
09/23/16
NO CHANGE
Target $175
BARD
Outperform
Costco weakness a buying opportunity, says Baird
Baird analyst Peter Benedict recommends buying Costco (COST) on its pullback as he believes the shares offer a compelling value proposition. The analyst also sees Costco as having a loyal membership model that remains a positive in today's challenging retail world. Benedict sees better traffic/sales later this year as comps ease and members recognize the benefits of the new co-branded Visa (V) card. He reiterated his Outperform rating and $175 price target on Costco shares.
09/23/16
LEHM
09/23/16
INITIATION
Target $158
LEHM
Equal Weight
Costco assumed with an Equal Weight at Barclays
Barclays analyst Karen Short assumed coverage of Costco with an Equal Weight rating and $158 price target. The rating is unchanged from the firm's prior coverage and the price target is lowered from $180.
09/12/16
JPMS
09/12/16
NO CHANGE
Target $179
JPMS
Overweight
Costco recent selloff a buying opportunity, says JPMorgan
JPMorgan analyst Christopher Horvers views the recent pullback in shares of Costco as a buying opportunity. The newly rolled out co-branded credit card should drive basket size and potentially traffic, Horvers tells investors in a research note. He believes Costco's "moderate" same-store-sales miss in August is a bright spot in retrospect given the subsequent negative preannouncements from peers. The analyst keeps an Overweight rating on the shares with a $179 price target.
10/03/16
BARD
10/03/16
NO CHANGE
Target $175
BARD
Outperform
Costco could see sluggish September comps, says Baird
Baird analyst Peter Benedict previewed September sales for Costco (COST). He believes comps could be sluggish as they are going against difficult comparisons. Looking ahead, however, he sees better traffic and sales as comparisons start to ease and members increasingly recognize the benefits of the new co-branded Visa (V) card. Benedict reiterated his Outperform rating and $175 price target on Costco shares.
V Visa
$81.90

-0.35 (-0.43%)

09/06/16
BARD
09/06/16
NO CHANGE
Target $48
BARD
Outperform
PayPal card deals long-term positive despite near-term margin impact, says Baird
After PayPal (PYPL) announced this morning that it has agreed to an expanded partnership with MasterCard (MA), Baird analyst Colin Sebastian said the new deal closely mirrors the company's recent agreement with Visa (V). He believes the partnerships with the card networks are a long-term positive for PayPal despite the likely negative near-term impact on margins, as he thinks PayPal's digital wallet will ultimately be more successful with the card networks' cooperation. Sebastian keeps an Outperform rating and $48 price target on PayPal shares.
10/05/16
BERN
10/05/16
NO CHANGE
BERN
Market Perform
Bernstein lays out six possible strategic outcomes for PayPal
After hosting a call to discuss PayPal's (PYPL) strategic options following its recently announced deals with Visa (V) and MasterCard (MA), Bernstein analyst Lisa Ellis laid out the potential strategic outcomes for PayPal that she foresees. In order from most to least likely: the most likely outcome PayPal's business model remains but that it shifts to debit centric vs. ACH; it is less likely, but a risk, that PayPal becomes a merchant acquirer; even less likely is that PayPal becomes a closed-loop. The chance that PayPal is acquired is "unlikely but less so" after the deals with the card majors, Ellis added. Lastly, she sees a "low probability" PayPal withers away or that it morphs into something else via acquisition. The firm has a Market Perform rating on PayPal shares.
AXP American Express
$60.35

-0.345 (-0.57%)

10/06/16
10/06/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Neutral from Buy at Goldman with analyst David Tamberrino saying he sees incremental risk to Tesla's business related to management's willingness to deploy capital for M&A, and he believes that any delay in the company's new Model 3 launch will be detrimental to shares. 2. JPMorgan (JPM) downgraded to Hold from Buy at Sandler O'Neill with analyst Jeffery Harte citing relative share outperformance. 3. Abercrombie & Fitch (ANF) downgraded to Sector Weight from Overweight at KeyBanc with analyst Jessica Schmidt saying the elevated promotions add to other headwinds, including the fact that the teen space is "overstored" and faces soft consumer demand and weak tourism. 4. American Express (AXP) downgraded to Reduce from Neutral at Nomura with analyst Bill Carcache saying the combination of weaker than expected revenues and higher than expected expenses will weigh on the shares. 5. Lowe's (LOW) downgraded to Neutral from Buy at Cleveland Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
ATLE
09/09/16
INITIATION
Target $62
ATLE
Underweight
American Express initiated with an Underweight at Atlantic Equities
Atlantic Equities initiated American Express with an Underweight and $62 price target.
09/09/16
09/09/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. American Express (AXP) initiated with an Underweight at Atlantic Equities. 2. Alcoa (AA) initiated with a Neutral at Seaport Global. 3. Blue Buffalo Pet Products (BUFF) initiated with an Outperform at Oppenheimer. 4. Harley-Davidson (HOG) initiated with an Outperform at Bernstein. 5. Verifone (PAY) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
NOMU
10/06/16
DOWNGRADE
Target $56
NOMU
Reduce
American Express downgraded to Reduce from Neutral at Nomura
Nomura analyst Bill Carcache downgraded American Express (AXP) to Reduce saying the combination of weaker than expected revenues and higher than expected expenses will weigh on the shares. The third quarter is the first quarter that American Express will report excluding Costco (COST), Carcache tells investors in a research note. He expects the "tug of war between bulls and bears to intensify" in Q3 and thinks 2016 will mark the fourth year of market share losses in U.S. billings. The analyst cut his price target for the shares to $56 from $62.
WFC Wells Fargo
$44.56

-0.765 (-1.69%)

10/13/16
BOFA
10/13/16
NO CHANGE
Target $48
BOFA
Buy
'Healing process' may now start for Wells shares, BofA/Merrill says
BofA/Merrill analyst Erika Najarian believes the departure of CEO, Chairman and President John Stumpf could begin a "healing process" for the shares of Wells Fargo. Consensus feedback from investors post the Congressional hearings is that Stumpf retiring may be a necessary step for the bank to begin putting the cross-sell controversy behind it, Najarian tells investors in a research note. The analyst expects the shares to react positively today on the news. She has a Buy rating on Wells Fargo with a $48 price target. The shares are down 9c to $45.23 in pre-market trading.
10/10/16
UBSW
10/10/16
UPGRADE
Target $44
UBSW
Neutral
Wells Fargo upgraded to Neutral from Sell at UBS
UBS analyst Brennan Hawken upgraded Wells Fargo to Neutral saying the risk/reward appears more balanced after the significant underperformance of the shares. The analyst believes Wells' earnings outlook remains uncertain, however. He keeps a $44 price target for the shares.
10/04/16
10/04/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Underperform from Market Perform at Raymond James with analyst David Long saying the fallout from the unauthorized account openings will result in continued under performance. The analyst said several additional investigations, lawsuits, and fines have been announced, resulting in a still cloudy outlook. 2. Kinder Morgan (KMI) downgraded to Hold from Buy at Stifel analyst Selman Akyol citing valuation. 3. GrubHub (GRUB) downgraded to Hold from Buy at Stifel with analyst John Egbert citing valuation. 4. Dr Pepper Snapple (DPS) downgraded to Hold from Buy at Evercore ISI with analyst Robert Ottenstein saying reports that Bai Brands is looking for a new owner are credible and could change investor's psychology on the stock and its Allied Brands business. 5. Dollar Tree (DLTR) downgraded to Neutral from Buy at Cleveland Research with the firm saying sales trends appear to have slowed further at Family Dollar as the company struggles with increased price competition, difficult comps, and strategy headwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/04/16
RAJA
10/04/16
DOWNGRADE
RAJA
Underperform
Wells Fargo downgraded to Underperform from Market Perform at Raymond James
Raymond James analyst David Long downgraded Wells Fargo to Underperform and reduced estimate saying the fallout from the unauthorized account openings will result in continued under performance. The analyst said several additional investigations, lawsuits, and fines have been announced, resulting in a still cloudy outlook.
JPM JPMorgan
$67.55

-0.58 (-0.85%)

10/06/16
SDLR
10/06/16
DOWNGRADE
Target $72
SDLR
Hold
JPMorgan downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Jeffery Harte downgraded JPMorgan to Hold citing relative share outperformance and maintained his $72 price target on shares.
09/28/16
DBAB
09/28/16
UPGRADE
Target $11.5
DBAB
Buy
Huntington Bancshares upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor upgraded Huntington Bancshares to Buy saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. The analyst views industry-wide concerns surrounding consumer indirect auto lending as overblown and he raised his price target for Huntington shares to $11.50 from $10.50. Going into the Q3 results for U.S. banks, O'Connor likes JPMorgan (JPM) and Wells Fargo (WFC) and is cautious on Fifth Third (FITB).
10/11/16
COMP
10/11/16
INITIATION
Target $50
COMP
Sell
JPMorgan initiated with a Sell at Compass Point
Compass Point analyst Charles Peabody initiated JPMorgan with a Sell and a $50 price target saying he expects earning growth to slow further in 2017 due to higher credit costs, tougher capital markets, and headwinds in wealth management, mortgage bank, and cards.
BAC Bank of America
$15.78

-0.25 (-1.56%)

09/13/16
SOCG
09/13/16
DOWNGRADE
Target $42
SOCG
Sell
Societe Generale cuts Citi to Sell, Bank of America to Hold
Societe Generale downgraded Citi (C) to Sell from Hold and Bank of America (BAC) to Hold from Buy. The firm has a $42 price target for shares of Citi and attributes an increased negative stance on Cards for the downgrade. Societe Generale has a $17 price target for Bank of America and cites revenue growth for the downgrade to Hold. Citi is trading down 86c to $46.93 and Bank of America is trading down 19c to $15.71.
09/16/16
GSCO
09/16/16
NO CHANGE
Target $19
GSCO
Conviction Sell
Bank of America operating leverage hitting an inflection, says Goldman
Goldman analyst Richard Ramsden believes Bank of America is hitting an inflection point in operating leverage driven by low single digit growth, stable credit, and absolute reductions in the expense base. The analyst believes topline growth will reach approximately 4% annually through to 2018, driven by consumer bank and wealth management initiatives. Ramsden reiterates his Conviction Buy rating on Bank of American and raised his price target to $19 from $17 given the combination of revenue growth and expense discipline.
10/11/16
COMP
10/11/16
INITIATION
Target $13
COMP
Neutral
Bank of America initiated with a Neutral at Compass Point
Compass Point analyst Charles Peabody initiated Bank of America with a Neutral and a $13 price target.
USB U.S. Bancorp
$42.76

-0.645 (-1.49%)

10/06/16
WEDB
10/06/16
INITIATION
Target $46
WEDB
Neutral
U.S. Bancorp initiated with a Neutral at Wedbush
Wedbush analyst Peter Winter initiated U.S. Bancorp with a Neutral and a $46 price target.
04/26/16
DBAB
04/26/16
DOWNGRADE
DBAB
Hold
U.S. Bancorp downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Matt O-Connor downgraded U.S. Bancorp to Hold saying the company's earnings momentum has stalled and that it can't currently acquire other banks.
07/06/16
BARD
07/06/16
NO CHANGE
BARD
Too early to buy the dip in bank stocks if rates stay this low, says Baird
Baird analyst David George said that lower reinvestment rates for securities should pressure net interest margin and earnings outlooks at banks and he recommends waiting until bank stocks reflect a greater discount for credit/recession risk before getting more aggressive in the space. While some management teams may choose to shrink balance sheets rather than reinvest at record-low yields, consensus earnings estimates in the sector should "trend meaningfully lower," George tells investors. Big banks among those covered by Baird include Bank of America (BAC), JPMorgan (JPM), U.S. Bancorp (USB) and Wells Fargo (WFC).
06/27/16
RBCM
06/27/16
NO CHANGE
RBCM
Some banks have reached attractive entry points, says RBC Capital
RBC Capital believes that banks may be hurt by the Fed's decision to delay raising interest rates in the wake of Brexit, and the firm admits that ucertainty regarding the EU membership of other countries could hurt U.S. banks going forward. However, the firm adds that "a silver lining" could be a boost to banks' fixed income businesses. Additionally, the firm thinks that the 10% decline in the shares of some banks "seems to be a bit premature," with the valuation of a number of banks falling to "low levels." It recommends that investors buy the following bank stocks: lBB&T (BBT), Huntington Bancshares (HBAN), JPMorgan (JPM), KeyCorp (KEY), M&T Bank (MTB), Northern Trust (NTRS), PNC Financial (PNC) and U.S. Bancorp (USB). The firm adds that "risk oriented investors should look to buy" Bank of America (BAC) and Citi (C).

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.